PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.\', \'Italian Society of Pharmacology, Milan, Italy.\', \'Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.\', \'Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.\', \'Azienda Zero - Department of Health of Veneto Region, Padua, Italy.\', \'Epidemiology Observatory - Department of Health of Lombardy Region, Milan, Italy.\', \'Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. stefania.spila@iss.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40264-020-00994-5
?:hasPublicationType
?:journal
  • Drug safety
is ?:pmid of
?:pmid
?:pmid
  • 32852721
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.447
?:rankingScore_hIndex
  • 112
is ?:relation_isRelatedTo_publication of
?:title
  • Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all